NewsCovering America

Actions

FDA says single-dose shot from J&J prevents severe COVID

Johnson & Johnson COVID-19 Vaccine
Posted at 5:23 AM, Feb 24, 2021
and last updated 2021-02-24 17:13:06-05

ASSOCIATED PRESS —WASHINGTON (AP) — An analysis by U.S. regulators says Johnson & Johnson's single-dose vaccine provides strong protection against severe COVID-19. The report Wednesday confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19. On Friday, a panel of experts to the Food and Drug Administration will debate if the evidence is strong enough to recommend the long-anticipated shot. The FDA is expected to make a final decision within days. If the FDA clears the J&J shot for U.S. use, it won’t boost vaccine supplies significantly right away. Only a few million doses are expected to be ready for shipping in the first week.